Recombinant antibodies coexpressed with GnTIII

Details for Australian Patent Application No. 2002307037 (hide)

International Classifications

Event Publications

19 December 2002 Complete Application Filed

Priority application(s): 60/280,139 02.04.01 US

3 April 2003 Application Open to Public Inspection

Published as AU-B-2002307037

4 November 2004 Change of Name(s) of Applicant(s), Section 104

Idec Pharmaceuticals Corporation The name of the applicant has been changed to Biogen Idec Inc. 2003

7 August 2008 Application Accepted

Published as AU-B-2002307037

4 December 2008 Standard Patent Sealed

27 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.